Back to Search
Start Over
A Review on Current Aspects of Curcumin-Based Effects in Relation to Neurodegenerative, Neuroinflammatory and Cerebrovascular Diseases.
- Source :
-
Molecules (Basel, Switzerland) [Molecules] 2024 Dec 26; Vol. 30 (1). Date of Electronic Publication: 2024 Dec 26. - Publication Year :
- 2024
-
Abstract
- Curcumin is among the most well-studied natural substances, known for its biological actions within the central nervous system, its antioxidant and anti-inflammatory properties, and human health benefits. However, challenges persist in effectively utilising curcumin, addressing its metabolism and passage through the blood-brain barrier (BBB) in therapies targeting cerebrovascular diseases. Current challenges in curcumin's applications revolve around its effects within neoplastic tissues alongside the development of intelligent formulations to enhance its bioavailability. Formulations have been discovered including curcumin's complexes with brain-derived phospholipids and proteins, or its liposomal encapsulation. These novel strategies aim to improve curcumin's bioavailability and stability, and its capability to cross the BBB, thereby potentially enhancing its efficacy in treating cerebrovascular diseases. In summary, this review provides a comprehensive overview of molecular pathways involved in interactions of curcumin and its metabolites, and brain vascular homeostasis. This review explores cellular and molecular current aspects, of curcumin-based effects with an emphasis on curcumin's metabolism and its impact on pathological conditions, such as neurodegenerative diseases, schizophrenia, and cerebral angiopathy. It also highlights the limitations posed by curcumin's poor bioavailability and discusses ongoing efforts to surpass these impediments to harness the full therapeutic potential of curcumin in neurological disorders.
- Subjects :
- Humans
Animals
Blood-Brain Barrier metabolism
Blood-Brain Barrier drug effects
Biological Availability
Curcumin therapeutic use
Curcumin pharmacology
Neurodegenerative Diseases drug therapy
Neurodegenerative Diseases metabolism
Cerebrovascular Disorders drug therapy
Cerebrovascular Disorders metabolism
Neuroinflammatory Diseases drug therapy
Neuroinflammatory Diseases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1420-3049
- Volume :
- 30
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Molecules (Basel, Switzerland)
- Publication Type :
- Academic Journal
- Accession number :
- 39795101
- Full Text :
- https://doi.org/10.3390/molecules30010043